ジメモルファンリン酸塩 shortage — JP supply status & alternatives

ジメモルファンリン酸塩

—

In supply · Australia

ジメモルファンリン酸塩ｄｓ小児用２．５％「タカタ」

In supply · 🇦🇺 Australia · short in🇯🇵 JP

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Therapeutic category
Active ingredient (INN)	ジメモルファンリン酸塩
Brand names	ジメモルファンリン酸塩ｄｓ小児用２．５％「タカタ」

Controlled substance	No

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Verified timeline regulator events

🇯🇵 1 July 2026

critical reported

🇯🇵 20 June 2026

medium reported

🇯🇵 18 June 2026

medium reported

🇯🇵 10 June 2026

medium reported

🇯🇵 8 June 2026

medium reported

🇯🇵 4 June 2026

medium reported

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.